ArticlePharmaceutics2020

Reduction-Responsive Molecularly Imprinted Poly(2-isopropenyl-2-oxazoline) for Controlled Release of Anticancer Agents.

Michał Cegłowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.